Wedbush Reaffirms Outperform Rating for Aerovate Therapeutics (NASDAQ:AVTE)
Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a report released on Tuesday, Benzinga reports. They currently have a $41.00 target price on the stock. Wedbush’s target price points to a potential upside of 95.15% from the stock’s current price. Wedbush also issued estimates […]
More Stories
Garner Asset Management Corp Has $2.41 Million Stake in QUALCOMM Incorporated (NASDAQ:QCOM)
Garner Asset Management Corp trimmed its holdings in QUALCOMM Incorporated (NASDAQ:QCOM – Free Report) by 0.8% in the third quarter,...
Capital Investment Counsel LLC Raises Stock Holdings in The Progressive Co. (NYSE:PGR)
Capital Investment Counsel LLC raised its position in shares of The Progressive Co. (NYSE:PGR – Free Report) by 3.2% in...
Baltimore Washington Financial Advisors Inc. Buys Shares of 1,029 AbbVie Inc. (NYSE:ABBV)
Baltimore Washington Financial Advisors Inc. purchased a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the...
Garner Asset Management Corp Trims Position in Alphabet Inc. (NASDAQ:GOOG)
Garner Asset Management Corp trimmed its holdings in Alphabet Inc. (NASDAQ:GOOG – Free Report) by 1.5% in the third quarter,...
Summit Trail Advisors LLC Grows Stock Position in Oracle Co. (NYSE:ORCL)
Summit Trail Advisors LLC grew its holdings in shares of Oracle Co. (NYSE:ORCL – Free Report) by 33.0% in the...
Von Berge Wealth Management Group LLC Has $230,000 Position in Mastercard Incorporated (NYSE:MA)
Von Berge Wealth Management Group LLC cut its stake in shares of Mastercard Incorporated (NYSE:MA – Free Report) by 7.6%...